Dimed S.A. Distribuidora de Medicamentos (PNVL3.SA)
BRL 9.03
(-1.63%)
BRL 9.03
(-1.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.46 Billion | 3.99 Billion | 3.22 Billion | 2.81 Billion | 2.72 Billion | 2.43 Billion |
| Cost of Revenue | 3.28 Billion | 2.74 Billion | 2.23 Billion | 1.99 Billion | 1.91 Billion | 1.71 Billion |
| Gross Profit | 1.17 Billion | 1.24 Billion | 988.59 Million | 823.69 Million | 808.91 Million | 715.99 Million |
| Operating Expenses | 1.03 Billion | 1.1 Billion | 885.64 Million | 729.52 Million | 681.71 Million | 605.38 Million |
| Selling, General and Administrative Expenses | 1.03 Billion | 220.14 Million | 179.66 Million | 149 Million | 160.98 Million | 141.24 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4.83 Million | 884.67 Million | 705.98 Million | 580.51 Million | 520.73 Million | 1.06 Million |
| Cost and Expenses | 4.29 Billion | 3.85 Billion | 3.12 Billion | 2.72 Billion | 2.59 Billion | 2.32 Billion |
| Operating Income | 166.57 Million | 149.01 Million | 121.61 Million | 77.85 Million | 117 Million | 111.61 Million |
| Interest Expense | 102.57 Million | 70.02 Million | 37.12 Million | 35.3 Million | 34.97 Million | 11.45 Million |
| Income Tax Expense | -1.32 Million | -7.91 Million | 3.81 Million | -2.84 Million | 4.08 Million | 17.63 Million |
| Earnings before Tax | 91.58 Million | 78.43 Million | 83.23 Million | 53.3 Million | 80.84 Million | 92.62 Million |
| Net Income | 92.9 Million | 86.34 Million | 79.42 Million | 56.15 Million | 76.75 Million | 74.98 Million |
| Earnings Per Share Basic | 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | 0.55 |
| Earnings Per Share Diluted | 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | 0.55 |
| Weighted Average Shares Outstanding | 148.7 Million | 148.57 Million | 149.59 Million | 151.31 Million | 135.74 Million | 136.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 149.71 Million | 149.14 Million | 149.9 Million | 151.51 Million | 135.74 Million | 136.52 Million |
| Gross Margin | 0.26 | 0.31 | 0.31 | 0.29 | 0.30 | 0.29 |
| EBIT Margin | 0.09 | 0.08 | 0.09 | 0.07 | 0.08 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| EBITDA | 396.86 Million | 335.82 Million | 260.55 Million | 211.17 Million | 213.27 Million | 138.51 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.13 Billion | 1.22 Billion | 1.22 Billion | 4.46 Billion | 1.13 Billion | 1.08 Billion |
| Cost of Revenue | 821.62 Million | 883.33 Million | 895.78 Million | 3.28 Billion | 787.34 Million | 737.63 Million |
| Gross Profit | 311.9 Million | 342.76 Million | 326.3 Million | 1.17 Billion | 342.8 Million | 343.74 Million |
| Operating Expenses | 286.41 Million | 292.92 Million | 294.44 Million | 1.03 Billion | 300.2 Million | 303.53 Million |
| Selling, General and Administrative Expenses | 286.41 Million | 292.92 Million | 294.44 Million | - | 303.78 Million | 303.92 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.15 Million | 78 Thousand | 86 Thousand | 379 Thousand | - | - |
| Cost and Expenses | 1.1 Billion | 1.17 Billion | 1.19 Billion | 4.31 Billion | 1.08 Billion | 1.04 Billion |
| Operating Income | 25.48 Million | 49.84 Million | 31.85 Million | 142.96 Million | 55.38 Million | 48.61 Million |
| Interest Expense | 36.61 Million | 25.34 Million | 25.71 Million | 102.57 Million | 31.76 Million | 27.54 Million |
| Income Tax Expense | 102 Thousand | -4.51 Million | -1.29 Million | -1.32 Million | -26 Thousand | -966 Thousand |
| Earnings before Tax | 5.23 Million | 29.03 Million | 27.72 Million | 91.58 Million | 23.61 Million | 21.06 Million |
| Net Income | 5.13 Million | 33.55 Million | 29.01 Million | 92.9 Million | 23.64 Million | 22.03 Million |
| Earnings Per Share Basic | 0.03 | 0.23 | 0.19 | - | 0.16 | 0.15 |
| Earnings Per Share Diluted | 0.03 | 0.22 | 0.19 | - | 0.16 | 0.15 |
| Weighted Average Shares Outstanding | 149.35 Million | 148.85 Million | 148.85 Million | 148.7 Million | 148.85 Million | 148.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 149.35 Million | 149.88 Million | 149.85 Million | 149.71 Million | 148.85 Million | 148.85 Million |
| Gross Margin | 0.28 | 0.28 | 0.27 | 0.26 | 0.30 | 0.32 |
| EBIT Margin | 0.07 | 0.08 | 0.07 | - | 0.09 | 0.09 |
| Profit Margin | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 77.23 Million | 101.31 Million | 82.55 Million | - | 105.45 Million | 98.39 Million |
| Earnings Before Tax Margin | 0.02 | 0.04 | 0.03 | 0.03 | 0.05 | 0.04 |
2022
DXLG
CMCO
0606
009310
2012